Browsing Tag
ASX healthcare
2 posts
Can PYC Therapeutics (ASX: PYC) turn clean safety data into investor confidence as ADOA trial expands?
PYC Therapeutics advances its RNA-based ADOA drug PYC-001 into a global Phase 1/2 multi-dose trial after a successful safety review. Find out what it means for biotech investors and patients.
Uscom Limited (ASX: UCM) bets on Singapore lifeline: What the AXO Medtech deal means for shareholders now
Uscom Limited (ASX: UCM) will sell its business to Singapore’s AXO Medtech for AUD 2.59M. Find out how this deal impacts investors and the company’s future.